Company / Return on Equity (ROE)
Disc Medicine, Inc. Return on Equity (ROE) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-28.7%
FY2025
5-year range
-28.7% / -22.1%
FY2022-FY2025
Trend
-16.3%
vs FY2024
Sector context
#92 of 190
Health Care
What the data says
Disc Medicine, Inc. reports negative total equity of -28.7% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-28.7% in FY2025 with a 3-year CAGR of -2.2%.
Declined from -22.1% to -28.7% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -2.2pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#92 of 190 in Health CareTop 48% of 190This company -28.7% Sector average -50.4%
▼
+43.1% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 16.3% year-over-year.
- Currently 21.7pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -28.7% | -16.3% |
| FY2024 | -24.6% | -11.3% |
| FY2023 | -22.1% | +16.5% |
| FY2022 | -26.5% | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026